作者:Aaron Smith、Zhi-Jie Ni、Daniel Poon、Zilin Huang、Zheng Chen、Qiong Zhang、Laura Tandeske、Hanne Merritt、Kevin Shoemaker、John Chan、Susan Kaufman、Kay Huh、Jeremy Murray、Brent A. Appleton、Sandra W. Cowan-Jacob、Clemens Scheufler、Takanori Kanazawa、Johanna M. Jansen、Darrin Stuart、Cynthia M. Shafer
DOI:10.1016/j.bmcl.2017.10.047
日期:2017.12
A series of imidazo[1,2-a]pyridin-6-yl-benzamide analogs was designed as inhibitors of B-RAFV600E. Medicinal chemistry techniques were employed to explore the SAR for this series and improve selectivity versus P38 and VEGFR2.
设计了一系列咪唑并[1,2 - a ]吡啶-6-基-苯甲酰胺类似物作为B-RAF V600E的抑制剂。药物化学技术用于探索该系列的SAR,并相对于P38和VEGFR2提高选择性。